Name | 2-(4-methyl-8-morpholin-4-ylsulfonyl-1,3-dioxopyrrolo[3,4-c]quinolin-2-yl)ethyl acetate |
---|---|
Synonyms |
2-[4-Methyl-8-(morpholin-4-ylsulfonyl)-1,3-dioxo-1,3-dihydro-2H-pyrrolo[3,4-c]quinolin-2-yl]ethyl acetate
1H-Pyrrolo[3,4-c]quinoline-1,3(2H)-dione, 2-[2-(acetyloxy)ethyl]-4-methyl-8-(4-morpholinylsulfonyl)- IVACHTIN Caspase-3 Inhibitor VII HMS3269H15 2-[4-Methyl-8-(4-morpholinylsulfonyl)-1,3-dioxo-1,3-dihydro-2H-pyrrolo[3,4-c]quinolin-2-yl]ethyl acetate |
Description | Ivachtin (Caspase-3 Inhibitor VII; compound 7a) is a nonpeptide, noncompetitive and reversibl caspase-3 inhibitor with an IC50 of 23 nM. Ivachtin has modest selectivity for the remaining caspases[1]. |
---|---|
Related Catalog | |
Target |
Caspase-3:23 nM (IC50) |
In Vitro | Ivachtin (Caspase-3 Inhibitor VII; compound 7a; 10, 100 μM) has protective effect in a model of staurosporininduced apoptosis in human Jurkat T cells[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 665.0±65.0 °C at 760 mmHg |
Molecular Formula | C20H21N3O7S |
Molecular Weight | 447.462 |
Flash Point | 356.0±34.3 °C |
Exact Mass | 447.110016 |
PSA | 131.56000 |
LogP | 1.30 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.632 |
Precursor 4 | |
---|---|
DownStream 0 |